Used as an intermediate in pharmaceutical synthesis, particularly in the development of neuroprotective and cognitive-enhancing agents. Its structure supports blood-brain barrier penetration, making it valuable in the design of nootropic drugs. Commonly employed in the preparation of fluorinated analogs to improve metabolic stability and bioavailability in central nervous system therapies. Also utilized in radiolabeling studies with fluorine-18 for positron emission tomography (PET) imaging due to the presence of fluorine in the propyl chain.